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he growth and repair of skeletal muscle after birth
depends on satellite cells that are characterized by
the expression of Pax7. We show that Pax3, the
paralogue of Pax7, is also present in both quiescent and
activated satellite cells in many skeletal muscles. Dominant-
negative forms of both Pax3 and -7 repress 
 
MyoD
 
, but
do not interfere with the expression of the other myogenic
determination factor, Myf5, which, together with Pax3/7,
regulates the myogenic differentiation of these cells. In
 
Pax7
 
 mutants, satellite cells are progressively lost in both
T
 
Pax3-expressing and -nonexpressing muscles. We show
that this is caused by satellite cell death, with effects on
the cell cycle. Manipulation of the dominant-negative
forms of these factors in satellite cell cultures demon-
strates that Pax3 cannot replace the antiapoptotic
function of Pax7. These ﬁndings underline the importance
of cell survival in controlling the stem cell populations of
adult tissues and demonstrate a role for upstream factors
in this context.
 
Introduction
 
Pax
 
 genes play key roles during development. Members of this
family of paired box/homeodomain transcription factors regu-
late the contribution of progenitor cells to different tissue types
(Tremblay and Gruss, 1994). 
 
Pax3
 
 and its paralogue 
 
Pax7
 
 have
been implicated in the specification of cells that will enter the
myogenic program. In the absence of both Pax3 and -7, there is
a major deficit in skeletal muscle, with arrest of myogenesis
occurring during later embryonic and fetal development (Relaix
et al., 2005). Cells in which the genes are activated become
incorporated into other tissues or die in the double mutants.
Normally, Pax3/7-positive skeletal muscle progenitor cells,
which are derived from the central dermomyotome region of
the somites (Ben-Yair and Kalcheim, 2005; Gros et al., 2005),
activate the myogenic regulatory genes and differentiate into
skeletal muscle fibers or remain as a proliferating reserve cell
population within the muscle mass (Gros et al., 2005; Kassar-
Duchossoy et al., 2005; Relaix et al., 2005). In late-stage fetal
muscle, these cells begin to adopt a satellite cell position
(Kassar-Duchossoy et al., 2005; Relaix et al., 2005), suggesting
that this somite-derived population also provides the progenitor
cells of postnatal skeletal muscle (Gros et al., 2005). In these
cells, the expression of 
 
Myf5
 
 and 
 
MyoD
 
 results in muscle cell
determination. During the formation of early embryonic skele-
tal muscle in the somite, Myf5 and Mrf4 play a critical role in
myogenic progenitors, which at this stage are derived from the
edges of the dermomyotome (Braun et al., 1992; Tajbakhsh et
al., 1996; Kassar-Duchossoy et al., 2004). Pax7 is not ex-
pressed in these cells in the mouse, where Pax3 is present.
Early myogenesis occurs in the 
 
Pax3
 
 mutant; however, in a
triple 
 
Pax3
 
/
 
Myf5
 
(
 
Mrf4
 
) mutant no skeletal muscle forms and
MyoD, which is required for skeletal muscle determination in
the absence of Myf5 and Mrf4, is not expressed (Tajbakhsh et
al., 1997). Therefore, Pax3, together with Myf5/Mrf4, regu-
lates the activation of 
 
MyoD
 
. Consistent with this conclusion,
 
MyoD
 
 is up-regulated in embryos in which PAX3-FKHR,
which acts as a strong transcriptional activator, has been tar-
geted to an allele of 
 
Pax3
 
 (Relaix et al., 2003). Pax3 is essential
for the survival of cells at the edges of the dermomyotome, par-
ticularly to those located hypaxially, where it is also required
for the delamination and migration of muscle progenitor cells
to other sites where skeletal muscle will form, such as the limbs
(Franz et al., 1993; Bober et al., 1994; Goulding et al., 1994).
When the coding sequence is targeted to the 
 
Pax3
 
 gene, Pax7
can substitute for Pax3 function in the trunk, but not in the
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limbs, suggesting that after the duplication of a common 
 
Pax3/7
 
gene, which is present before vertebrate radiation, the functions
of Pax3 and -7 diverge in response to the requirements of
appendicular muscle formation (Relaix et al., 2004).
Satellite cells, the myogenic progenitor cells of postnatal
muscle, lie under the basal lamina of muscle fibers in a quies-
cent state until they become activated, proliferate, and form
new skeletal muscle, which occurs during postnatal growth and
in response to damage (Bischoff and Heintz, 1994). Myogenic
regulatory genes are expressed during this process; 
 
Myf5
 
 is al-
ready expressed in quiescent satellite cells (Beauchamp et al.,
2000), and 
 
MyoD
 
 is expressed as the cells become activated
and subsequently differentiate with the expression of 
 
myogenin
 
(Yablonka-Reuveni and Rivera, 1994). 
 
Myf5
 
:
 
MyoD
 
 double
mutants have not yet been examined in this adult context be-
cause of the perinatal lethality of the original 
 
Myf5
 
 mutant.
However, in the absence of MyoD, muscle regeneration is less
efficient and the balance between proliferation and differentia-
tion of myosatellite cells appears to be affected (Megeney et
al., 1996). The most striking result, however, came from the
examination of 
 
Pax7
 
 mutant mice (Seale et al., 2000). Pax7 is
present in satellite cells, and in its absence muscle regeneration
is severely affected. Satellite cells were not observed in the mu-
tant, leading to the proposal that Pax7 is essential for the speci-
fication of adult muscle progenitor cells (Seale et al., 2000).
However, it has recently been shown that satellite cells are
present in the 
 
Pax7
 
 mutant, although in decreasing numbers as
the mice mature, and it has been suggested that their prolifera-
tion is compromised in the absence of Pax7 (Oustanina et al.,
2004). Pax7 is present in quiescent satellite cells and during
their activation, but is down-regulated when they differentiate.
A proportion of activated satellite cells remain undifferentiated,
retain Pax7 expression, and are thought to reconstitute the sat-
ellite cell pool (Olguin and Olwin, 2004; Zammit et al., 2004).
Therefore, Pax7 appears to play a predominant role in adult
muscle progenitor cells. The presence of Pax3, however, has
been noted after satellite cell activation, leading to the pro-
posal that it is implicated in their proliferation (Conboy and
Rando, 2002). It was also noted that the expression of a
 
Pax3
 
nLacZ
 
 allele can be detected in quiescent satellite cells
(Buckingham et al., 2003).
We now investigate the role of Pax7 in relation to Pax3,
which we show is expressed in the quiescent satellite cells of a
major subset of skeletal muscles. We show that both Pax3 and -7
control 
 
MyoD
 
 activation, and therefore regulate myogenesis in
the adult. However, we demonstrate that in the absence of Pax7
satellite cells are progressively lost postnatally because of
apoptosis accompanied by cell cycle defects. Pax7 has a critical
antiapoptotic function in activated satellite cells for which
Pax3 does not compensate. These results underline the critical
role of upstream regulators of tissue formation and regenera-
tion in assuring progenitor cell survival.
 
Results
 
Pax3
 
 expression in the satellite cells of 
adult skeletal muscle
 
Because Pax3 plays a key role during the onset of skeletal
myogenesis in the embryo, we investigated its status in adult
muscle in relation to Pax7. Analysis of adult mice in which the
 
Pax3
 
 gene is targeted with 
 
nLacZ
 
 reporters (Relaix et al., 2003)
revealed the presence of 
 
 
 
-galactosidase (
 
 
 
-gal)–positive cells
in adult skeletal muscle. The number of such cells varies between
muscles. They are particularly abundant in the diaphragm
Figure 1. Pax3 expression in muscle satellite cells. (A–C)
Expression of Pax3 in different muscles from 3-wk-old
Pax3
IRESnLacZ/  mice, revealed by X-Gal staining. (A) Dia-
phragm muscle; (B) hindlimb muscles, (g) gracilis muscle;
(C) trunk muscles, (sdc) serratus dorsalis caudalis. (D)
Semiquantitative RT-PCR of Pax3 and -7 transcripts in
adult tibialis anterior (TA) and diaphragm muscle. The
number of cycles is indicated on the top of each lane. M,
molecular weight markers (see Materials and methods).
(D’) Pax3 protein is detected by Western blot in protein
extracts from different muscles (D, diaphragm; L, hind-
limb; T, ventral trunk muscles) in 3-wk-old mice. Tubulin
(Tub) expression is shown as a loading control. (E and F)
Pax3
IRESnLacZ/  is expressed in a subset of diaphragm
muscle nuclei (arrows) from 3-wk-old mice, as revealed
by X-Gal and DAPI staining of a transverse section (E) or
isolated fiber (F). (G and G’) Detection of Pax3/7-depen-
dent  -gal expression in transverse sections of adult dia-
phragm muscle from the transgenic line P34, which re-
ports Pax3/7 transcriptional activity. (G) Immunodetection
of laminin (red) and DAPI (blue) staining. (G’) Coimmuno-
detection of laminin (red) and  -gal (green). (H–J’)
Coimmunodetection of  -gal–positive cells in the dia-
phragm muscle of 3-wk-old Pax3
IRESnLacZ/  mice with
laminin (H’, green), CD34 (I’, red), or M-cadherin (J’, red).
As indicated in the figure,  -gal is shown in red in H’ and
in green in I’ and J’. Corresponding DAPI staining is
shown (H, I, and J) for each panel. Arrows indicate the
labeled satellite cell nuclei. (K) Coimmunodetection of Pax3 (red) and laminin (green, K’). Corresponding DAPI staining is shown, with the labeled nucleus
indicated by an arrow (K). (L–N’) Coimmunohistochemistry on diaphragm muscle from 3-wk-old Pax3
IRESnLacZ/  mice for Pax7 (red) or  -gal (green).
(L–N) Corresponding DAPI staining is presented with labeled nuclei indicated by arrows for each panel. 
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(Fig. 1 A), but are much less frequent in hindlimb muscles,
with the exception of the gracilis muscle (Fig. 1 B). In contrast,
 
 
 
50% of forelimb muscles express 
 
Pax3
 
. As in the embryo
(Relaix et al., 2004), expression of 
 
Pax3
 
 is not detectable in
head muscles. Most ventral trunk muscles are positive, with a
striking juxtaposition in the rib area, where intercostal muscles
are mainly negative, whereas body wall muscles such as the
serratus caudalis dorsalis are positive (Fig. 1 C). This differ-
ence is confirmed by semiquantitative RT-PCR analysis of
Pax3 versus -7 transcripts in the tibialis anterior hindlimb mus-
cle compared with the diaphragm (Fig. 1 D). The Pax3 protein
is also present, as shown by Western blot analysis of different
muscles (Fig. 1 D’). The 
 
Pax3
 
nlacZ/
 
 
 
-expressing cells are found
to be associated with muscle fibers (Fig. 1, E and F). The Pax3/7
protein is transcriptionally active in adult muscle, as indicated
by activation of the P34 reporter transgene in which Pax3/7
binding sites regulate 
 
nLacZ
 
 expression (Fig.1, G and G’; Relaix
et al., 2004). These Pax3-expressing nuclei are present in satel-
lite cells, as shown by coimmunolocalization of 
 
 
 
-gal with the
satellite cell markers CD34 and M-cadherin and by the inclu-
sion of 
 
 
 
-gal–positive cells within the basal lamina of the muscle
fiber (Fig. 1, H–K’). Because Pax7 is present in satellite cells
(Seale et al., 2000), the question of Pax3 expression in relation
to Pax7 was addressed. In the diaphragm, the majority of Pax7-
positive satellite cells also coexpress Pax3. About 15% of the
cells only label with Pax7, and, occasionally, cells that express
only Pax3 are also detected (
 
 
 
3%; Fig. 1, L–N’). We therefore
conclude that Pax3, like Pax7, is expressed in quiescent satel-
lite cells and that the frequency of this event varies between
muscles. There is no direct relation to fiber type (Kelly and
Figure 2. Pax3 and -7 expression in activated satellite cells. (A–F) Coimmunocytochemistry on primary cultures derived from the trunk muscles of 3-wk-old
Pax3
nLacZ/  mice after 4 d in culture, using DAPI staining (A and D), or an antibody recognizing  -gal (Pax3; B and E, red), MyoD (C, green) or Pax7 (F, green).
Whereas  -gal (Pax3) and MyoD are coexpressed in proliferating myoblasts, upon terminal differentiation Pax3 ( -gal) is down-regulated (A–C, arrow-
heads), and is already lower in some mononucleated MyoD-positive cells (A–C, arrow). (E and F) Most colonies coexpress  -gal (Pax3) and Pax7. (G–L)
Detection of GFP and myogenin in primary cultures of satellite cells from the diaphragm of 3-wk-old Pax3
GFP/  mice after 5 d in culture; (G and J) DAPI
staining; (H and K) direct detection of GFP (Pax3) fluorescence (green); and (I and L) immunodetection of myogenin (red). (M–R) Coimmunocytochemistry
on primary cultures derived from the hindlimb muscles of 3-wk-old Pax3
nLacZ/  mice after 4 d in culture, showing DAPI staining (M and P) or reaction with
an antibody recognizing  -gal (N and Q, red) or Pax7 (O and R, green). Colonies expressing either Pax7 alone (N and O) or Pax3 and -7 (Q and R;
 20%, see S) were identified. (S) Histograms showing the percentage (%) of  -gal (Pax3)–positive colonies of myogenic cells obtained from the dia-
phragm (Diaph.), ventral trunk (Trunk), and hindlimb (Limb) muscles of 3-wk-old Pax3
nLacZ/  mice. Cells were plated at low density to permit the formation
of colonies and stained with X-Gal 3–4 d after plating. The results are from three independent experiments after counting  100 colonies from triplicate cul-
ture plates. (T and U) Muscle satellite cells were isolated by flow cytometry from the lower hindlimb muscles and from the diaphragm of Pax3
GFP/  adult
mice as (Pax3) GFP-negative and (Pax3) -positive cells and maintained in culture as proliferating cells for 6 d before analysis of GFP expression by flow
cytometry. Direct detection of GFP was performed on living cells under an inverted fluorescence microscope (T and U, top left) with corresponding phase-
contrast detection of the cells (T and U, bottom left) and flow cytometry detection of GFP-positive cells (T and U, right, boxed R2 region). 
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Rubenstein, 1994) because the diaphragm muscle (type IIX,
IIA, and I fibers) is positive, whereas in the hindlimb the soleus
(type I and IIA) is negative. Similarly, in the hindlimb the gas-
trocnemius (mostly type IIB) is negative, whereas other fast
muscles (type IIA and IIB) in the trunk and forelimb have
Pax3-expressing satellite cells.
We next examined the expression of Pax3 and -7 in pri-
mary cultures of satellite cells prepared from different muscles
(Fig. 2). Activated satellite cells, from the trunk muscle of
 
Pax3
 
IRESnLacZ/
 
 
 
 mice, which are Pax3 (
 
 
 
-gal)-positive, also ex-
press MyoD and down-regulate Pax3 (
 
 
 
-gal) in differentiated
muscle fibers (Fig. 2, A–C). This is also seen in cultures from
 
Pax3
 
GFP/
 
 
 
 mice (Relaix et al., 2005), where expression of myo-
genin, which marks the onset of differentiation, is associated
with rapid reduction in Pax3 (GFP) expression (Fig. 2, G–L).
MyoD-positive cells in which Pax3 (
 
 
 
-gal) is low (Fig. 2, B
and C) have probably activated 
 
myogenin
 
. MyoD (Fig. 2 C), or
later myogenin (Fig. 2, I and L), is expressed in most cells
marked by DAPI staining. In cultures from trunk (Fig. 2, D–F)
and diaphragm muscle (not depicted), most nondifferentiating
satellite cells coexpress Pax3 (
 
 
 
-gal) and -7. However, in cul-
tures from the hindlimb of 
 
Pax3
 
IRESnLacZ/
 
 
 
 mice this is not the
case and many colonies only express Pax7 (Fig. 2, N and O).
Some colonies (
 
 
 
20%) express both 
 
Pax
 
 genes (Fig. 2, P–R).
The distribution of these two types of colonies from different
muscle sources is quantified in Fig. 2 S. To confirm that 
 
Pax3
 
is not activated in satellite cells that only express 
 
Pax7
 
, we iso-
lated these cells using flow cytometry. Based on the isolation
of GFP-positive satellite cells from the diaphragm muscle, we
had previously established the gating window that contains
these cells (Montarras et al., 2005), which is shown as a boxed
area (R2) in Fig. 2 (T and U). When satellite cells isolated on
this basis from the diaphragm muscle are cultured and reana-
lyzed by flow cytometry, they remain Pax3 (GFP)-positive
(Fig. 2 T). However, when Pax3-negative satellite cells are
sorted from the muscle of the lower hindlimb and cultured, no
GFP-positive cells were found in the R2 window after re-sorting
by flow cytometry (Fig. 2 U). These results demonstrate that
activated satellite cells from Pax3-negative muscles, do not
activate this 
 
Pax
 
 gene in cell culture.
 
The myogenic function of Pax3 and -7 in 
satellite cells
 
In the genetic hierarchy that regulates the onset of myogene-
sis in the embryo, Pax3 activates 
 
MyoD
 
 (Tajbakhsh et al.,
1997; Relaix et al., 2003), and Pax7 can replace Pax3 in this
function (Relaix et al., 2004). Therefore, we investigated the
myogenic activity of the two Pax proteins in adult muscle by
infecting cultured satellite cells with adenoviral vectors ex-
pressing wild-type or dominant-negative forms of Pax3 and -7,
together with a GFP reporter. The dominant-negative proteins
contain the repression domain of the 
 
Drosophila melano-
gaster 
 
engrailed transcription factor (Han and Manley, 1993)
fused to the NH
 
2
 
-terminal region of the Pax sequence, which
retains its DNA-binding domain. An initial series of experi-
ments was performed with satellite cells isolated from a Pax
reporter line, 
 
P34
 
, in which the transgenic mice express 
 
 
 
-gal
Figure 3. The effect of dominant-negative forms of Pax3 and -7 on MyoD
and Myf5 expression in satellite cells. (A) Primary cultures prepared from
adult diaphragm muscle from the Pax3/7 transcriptional reporter line, P34,
were infected with adenoviruses encoding either GFP alone (Adeno-GFP),
GFP and Pax3, GFP and Pax7, or GFP with dominant-negative versions of
either Pax3 (Pax3DN) or Pax7 (Pax7DN). (top) Infected cells are identified
as GFP positive. (bottom) The capacity of Pax3DN or -7DN to abrogate
Pax3/7 transcriptional activity is revealed by weaker (arrows) or undetect-
able X-Gal staining seen in  80% of GFP-positive cells with both dominant-
negative constructs. (B and C) Coimmunohistochemistry on primary cultures
from hindlimb or diaphragm muscles of 3-wk-old wild-type mice infected
with adenoviral vectors as in A. DAPI staining and antibodies recognizing
either Myf5 (B) or MyoD (C) were used, whereas GFP fluorescence was de-
tected directly. Cells expressing lower levels of PaxDN are indicated with
an arrowhead. (D) Quantitation of results for satellite cell cultures infected
with an adenovirus-expressing GFP and Pax3DN or GFP and Pax7DN, pre-
sented in B and C. Results presented as histograms of the percentage (%) of
GFP-positive cells expressing Myf5 or MyoD are taken from two to five inde-
pendent experiments. (E) Primary cultures of satellite cells isolated from the
diaphragm muscle of adult wild-type mice were infected with adenoviruses
expressing GFP and Pax3 or -7. Infected cells were identified by direct
detection of GFP fluorescence, and MyoD expression was followed by
immunodetection. (F) Primary cultures of muscle satellite cells from hindlimb
muscles of 3-wk-old Myf5
GFP/  and Myf5
GFP/GFP mice were infected with
adenoviral vectors encoding either GFP alone or GFP and Pax3DN or -7DN.
Infected cells are identified by GFP fluorescence, and myogenesis is moni-
tored by immunodetection of myogenin. The threshold of fluorescent GFP
detection was set to capture only the strong adenovirus GFP reporter,
excluding the weaker expression from the Myf5
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from an nLacZ reporter that is regulated by multimerized
Pax3/7 binding sites (Relaix et al., 2004). Overexpression of
Pax3 or -7 resulted in no obvious increase in reporter activity,
which was already expressed at a high level in the Pax3/7-
positive satellite cells. However, the dominant-negative ver-
sions of both of these factors (Pax3DN and -7DN) resulted in
down-regulation of the reporter (Fig. 3 A). With decreasing
levels of Pax3DN or -7DN, no significant difference in the re-
pression exerted by either dominant-negative Pax was detect-
able (not depicted). We conclude that Pax3 and -7 bind to the
consensus site with similar affinities and that their dominant-
negative forms compete effectively with both endogenous
proteins, which normally function as transcriptional activa-
tors in these adult muscle cells, as in the embryo (Relaix et
al., 2003). When dominant-negative forms of Pax3 or -7 were
expressed in satellite cell cultures, the level of the myogenic
factor Myf5 was not markedly affected (Fig. 3 B), whereas
MyoD was down-regulated in infected cells (Fig. 3 C). As for
the Pax3/7 reporter transgene, similar dosage effects were
seen for both Pax3DN and -7DN, with reduction, but not
elimination, of MyoD in cells in which the adenoviral expres-
sion vector was expressed at a lower level (Fig. 3 C, arrow-
heads). These results are quantified in Fig. 3 D. In contrast to
the striking down-regulation of MyoD seen with the dominant-
negative constructs, overexpression of wild-type Pax3 or -7 is
compatible with MyoD expression (Fig. 3 E). Because myo-
genesis still occurs in the absence of MyoD (Fig. 3 F and not
depicted), we investigated whether this is regulated by Myf5,
which is expressed independently of Pax3 or -7 in the satellite
cell cultures. These cells were prepared from hindlimb muscles of
Myf5
GFP/  and Myf5
GFP/GFP mice and infected with Pax3DN and
-7DN adenoviral vectors (Fig. 3 F). Unlike infected cells from het-
erozygous mice, Myf5 mutant cells do not express myogenin or
differentiate in the presence of the dominant-negative Pax vectors.
This demonstrates that either Pax3/7, acting via MyoD, or Myf5
are required for the myogenic differentiation of adult satellite cells.
The presence of satellite cells and 
muscle differentiation in Pax3-expressing 
muscles of Pax7 mutant mice
Because Pax3-expressing satellite cells are found in adult mus-
cles, their potential contribution to muscle growth and regener-
ation was investigated in the Pax7 mutant mouse. We first
evaluated whether Pax3 continues to be expressed in dia-
phragm and trunk muscles. This is the case as shown in Fig.
4 at postnatal day 3 (P3). Western blots show that Pax3 is
present, although at a reduced level (Fig. 4 A), and immunohis-
tochemistry confirms that Pax3 is expressed in satellite cells
(Fig. 4 B). Satellite cells are also revealed by  -gal labeling of
Pax7
LacZ/LacZ muscle at P2 (Fig. 4 C) and, indeed, even at P10
cultures from the diaphragm contain MyoD-positive cells that
differentiate into myofibers expressing troponin T (Fig. 4 D),
although such cells are much rarer ( 15% of wild type). Simi-
larly, single fiber experiments with the extensor digitorum lon-
gus hindlimb muscle (Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200508044/DC1) show that satellite cells
are still present in the mutant, but that their number is reduced
to  10% of normal levels at P10. The number of myonuclei is
also reduced by  50% at this stage (Fig. S1 F) and muscle fi-
bers are smaller (not depicted), consistent with the reduced size
of mutant mice (Mansouri et al., 1996; Seale et al., 2000). The
number of  -gal–positive satellite cells were counted on sec-
tions of Pax7
LacZ/LacZ muscles and compared with heterozygotes
at P2 and P11 (Fig. 4 E). At P2 there is only a small reduction
Figure 4. Pax3 expression is maintained in Pax7-deficient satellite cells.
(A) Western blot analysis of Pax3 expression in the diaphragm of
Pax7
LacZ/  ( / ) or Pax7
LacZ/LacZ ( / ) mice at P3. Tubulin (Tub) expres-
sion is shown as a loading control. (B) Coimmunohistochemistry on trans-
verse sections of ventral trunk muscle of Pax7
LacZ/LacZ mice at P2 using DAPI
staining and an antibody that recognizes Pax3. Laminin staining shows a
Pax3-positive cell (red) present in a satellite cell position. (C) Immunohis-
tochemistry on transverse sections of ventral trunk muscle from Pax7
LacZ/ 
or Pax7
LacZ/ LacZ mice at P2 using antibodies recognizing  -gal (green) and
laminin (red). Corresponding DAPI staining is indicated. Arrowheads indi-
cate Pax7 ( -gal)–expressing cells, located under the basal lamina. (D)
Coimmunocytochemistry on 7-d primary cultures derived from the dia-
phragm of Pax7
LacZ/  or Pax7
LacZ/LacZ mice at P10 using antibodies recog-
nizing MyoD and troponin T. (E) Quantification of the number of  -gal–
positive satellite cells in trunk, diaphragm (dia), and hindlimb (limb)
muscles of Pax7
LacZ/  ( / ) or Pax7
LacZ/LacZ ( / ) mice, detected per fi-
ber on 10- m sections from ventral trunk muscle at P2 or P11. (F) Infection
of primary cultures from Pax7
LacZ/LacZ mutant mice (Pax7
 / ) at P4 with an
adenovirus expressing a dominant-negative form of Pax3 (Adeno
GFP Pax3DN) shows elimination of MyoD expression in infected cells
(right arrowhead, infected cell; left arrowhead, noninfected cell), whereas
virus expressing GFP alone had no effect. Quantification is shown in G.
No MyoD-positive myogenic cells are present after Pax3DN infection.JCB • VOLUME 172 • NUMBER 1 • 2006 96
( 18%) in the numbers of satellite cells in trunk, diaphragm,
or hindlimb muscles. By P11, this reduction is striking ( 83%)
and is similar for all three muscle sources, whether Pax3 is ex-
pressed in most satellite cells (e.g., diaphragm) or not (hind-
limb). This demonstrates that Pax3 cannot compensate for
Pax7 function during the postnatal development of skeletal
muscle. This is not because of a failure in myogenesis in the
mutant satellite cells. MyoD is still expressed and, as in wild-
type cultures (Fig. 3), its expression is inhibited by a dominant-
negative form of Pax3 (Fig. 4, F and G).
Satellite cell proliferation in the 
Pax7 mutant
Because the numbers of satellite cells fall during postnatal devel-
opment in Pax7 mutant mice, and muscle fiber size is reduced, it
is possible that activated satellite cells, which contribute to
muscle growth, do not proliferate normally. This was examined
in primary cultures from the diaphragm and hindlimb muscles
of Pax7
LacZ/LacZ and Pax7
LacZ/  mice, plated at low density so
that the number of cells per colony could be monitored. A re-
duction of 25–30% in the number of cells per myogenic colony
was observed (Fig. 5 A), indicating that, in the absence of
Pax7, proliferation is affected and that this is also the case for
colonies from a muscle, such as the diaphragm, which ex-
presses Pax3. To determine whether some cells have with-
drawn from the cell cycle, a Ki67 antibody was used, which
marks proliferating cells in all phases of the cell cycle (Schol-
zen and Gerdes, 2000). There was no difference between
colonies from mutant or heterozygous mice, where the pro-
portion of proliferating cells is concerned (Fig. 5 B). We next
examined progression of cells through the cell cycle, using a
cyclin A antibody that marks cells in the S and G2 phases
(Girard et al., 1991). There were 33% more cyclin A–positive
cells in the mutant myogenic colonies (Fig. 5 C).
One possible explanation for the increase in the propor-
tion of proliferating cells in the S and G2 phases of the cycle in
the Pax7 mutant is that some cells exit the cycle during G1 and
immediately undergo apoptosis, resulting in a reduction in the
number of cells per colony observed in the absence of Pax7
(Fig. 5 A). In the colony assay, we did not detect a significant
difference in the numbers of dying cells using standard markers
of apoptosis (not depicted). This may be because such cells
detach immediately. Alternatively, there may be a cell cycle
defect independent of apoptosis, such as a cell cycle arrest in G2,
resulting in a slower progression through the cell cycle.
Apoptosis of satellite cells in the 
absence of Pax7
To investigate the survival of satellite cells in postnatal muscle
in vivo, in the absence of Pax7, we used an antibody to the acti-
vated form of caspase-3 to label cells undergoing apoptosis
(Patel et al., 1996). Coimmunohistochemistry was performed
with an antibody to desmin, which marks activated satellite
cells as they assume a myoblast phenotype (Creuzet et al.,
1998), as well as muscle fibers. In the postnatal trunk muscle of
Pax7 mutant mice, activated caspase-3–labeled cells are ob-
served, whereas in control mice labeled cells are not detected
(Fig. 6, A–D). These results are quantitated in Fig. 6 E. The de-
crease observed from P0 to P6 reflects the decreasing numbers
of satellite cells in the mutant. These cells also express desmin,
suggesting that they correspond to activated satellite cells,
probably contributing to the postnatal growth of muscle (Fig. 6,
A and B, arrowheads). The identification of these cells was
confirmed by labeling with a laminin (Fig. 6 C) or  -gal anti-
Figure 5. Satellite cell proliferation in the Pax7 mutant. (A) Satellite cells from the diaphragm (dia) or hindlimb muscles (limb) of Pax7
lacz/  ( / ) and
Pax7
lacz/lacz ( / ) mice at P4 were plated at low density. After 3 d, when colonies had formed, cells were processed for immunocytochemistry using a MyoD
antibody. The number of cells per myogenic colony was determined in three independent experiments for each type of muscle and after counting at least 10
colonies per experiment. Results are expressed as the percentage of cells per myogenic colony from the Pax7 mutant ( / ) with respect to Pax7 heterozygotes
( / ), taken as 100%. (B) Determination of the percentage of cycling cells in normal and mutant myogenic colonies cultured as in A. Cells were costained
with antibodies against MyoD and Ki67, which marks all phases of the cell cycle. Examples shown are for myogenic colonies from hindlimb muscles. Quan-
titation is from two independent experiments for each type of muscle. Results expressed as percentage of Ki67-positive cells per myogenic colony indicate that
both mutant and wild type cells proliferate equally well. (C) Determination of the percentage of cyclin A–positive cells per myogenic colony cultured as in A.
Cells were costained with antibodies against MyoD and cyclin A, which marks the S and G2 phases of the cell cycle. Examples shown are from hindlimb
muscles treated for immunocytochemistry as in B. Results are expressed as percentage of cyclin A–positive cells per myogenic colony.PAX7 IS ESSENTIAL FOR MUSCLE SATELLITE CELL SURVIVAL • RELAIX ET AL. 97
body (Fig. 6 D). The latter detects Pax7 transcription, which
marks satellite cells. During postnatal development, apoptotic
cells were detected in all trunk and limb muscles examined in
the Pax7 mutant, whereas they were very rare in the muscles of
normal mice (Fig. 6 E). Therefore, we conclude that Pax7 has
an antiapoptotic function and that in its absence satellite cells die,
despite the presence of Pax3.
To compare the roles of Pax3 and -7 in protecting against
apoptosis, wild-type satellite cells were transfected with GFP-
marked adenoviral vectors coexpressing a dominant-negative
form of Pax3 or -7. These cells were analyzed by flow cytometry
on the basis of GFP expression, and their viability was mea-
sured by propidium iodide (PI) staining, which detects dying
cells (Matteucci et al., 1999). Such an experiment is shown in
Fig. 7 A for cells from hindlimb muscle infected with a domi-
nant-negative form of Pax3 or -7, which led to 71% of dying
cells in the GFP-positive population when Pax7DN was ex-
pressed. The results of these experiments are summarized in
Fig. 7 B. Whereas Pax7DN led to substantial cell death, the
Pax3DN-expressing virus at similar or sixfold higher multiplic-
ities of infection did not show any effect on these cells, relative
to control values. Similar results were seen in primary cultures
from young mice (P7; not depicted) to those shown here for
3–4-wk-old animals (Fig. 7). No such apoptotic effect was ob-
served when muscle cultures were infected with adenoviral
vectors expressing Pax7. The induction of apoptosis is not
related to the presence of MyoD (Peschiaroli et al., 2002) be-
cause in satellite cell cultures from MyoD
 /  mice infected by
Figure 6. Satellite cell survival in Pax7 mutant
mice. (A) Coimmunohistochemistry on trans-
verse sections of ventral trunk muscle of
Pax7
LacZ/  or Pax7
LacZ/LacZ newborn mice at P0
or P3 using DAPI staining or antibodies recog-
nizing desmin (red) or the activated form of
caspase-3 (green). Apoptotic cells that are
desmin positive are present in muscles from
Pax7 mutant mice (arrowheads). (B) Coimmuno-
histochemistry on transverse sections of ven-
tral trunk muscle of Pax7
LacZ/  mice at P2 us-
ing DAPI staining or antibodies recognizing
desmin (red) or  -gal (green). Pax7 ( -gal)-
expressing satellite cells are either desmin
positive (arrows), which marks activated satel-
lite cells, or desmin negative (arrowheads), in-
dicating quiescent satellite cells. (C and D)
Coimmunohistochemistry on transverse sec-
tions of ventral trunk muscle of Pax7
LacZ/LacZ
mice at P2 (C) or P6 (D) using DAPI staining or
antibodies recognizing the activated form of
caspase-3 (green), laminin (C, red), or  -gal
(D, red) shows that the Pax7 mutant cells located
in a satellite cell position are subject to apoptosis. (E) Quantification of apoptotic cells at P0, P2, and P6, based on analysis of sections after coimmuno-
histochemistry with an antibody to activated caspase-3, and to desmin as a marker of muscle cells. Cells labeled with both antibodies were scored per
standard transverse section of trunk and forelimb muscle.
Figure 7. The role of Pax7 and -3 in the survival of
satellite cells. (A) An example of the data obtained by
flow cytometry after infection of cells cultured from hind-
limb muscles with a GFP-labeled adenovirus expressing
GFP alone or with a dominant-negative form of Pax3
(Pax3DN) or Pax7 (Pax7DN). The percentages indicate
the number of GFP-positive cells that are undergoing cell
death on the basis of PI uptake (R4) compared with those
that survive (R3). (B) A summary of results obtained from
the hindlimb on infection with both Pax7DN and
Pax3DN, based on four independent experiments with
triplicate cultures in each experiment. The numbers shown
in the histograms are the percentage of dying cells (R4).
Control experiments were performed with adenoviruses
expressing only GFP. Numbers in brackets indicate the
multiplicity of infection. (C) A summary of results obtained
for cells isolated from the diaphragm. The histograms
correspond to five independent experiments for the control
(5–30) and Pax3DN (5–10), two for Pax3DN (30), and
three for Pax7DN (5). Numbers in brackets indicate the
multiplicity of infection. (D) The number of MyoD-positive
colonies per culture dish obtained after plating the same
number of cells from hindlimb or diaphragm muscle of
Pax7
LacZ/  or Pax7
LacZ/LacZ mice at P4.JCB • VOLUME 172 • NUMBER 1 • 2006 98
Pax7DN a similar extent of cell death was observed (not de-
picted). Furthermore, Pax7DN (or Pax3DN) did not provoke
cell death in nonmyogenic cells, such as the OP9 bone mar-
row stromal cell line (not depicted). When cells isolated from
the diaphragm (Fig. 7 C) were similarly infected, cell death
caused by Pax7DN was about half of that witnessed in cells
from hindlimb muscle. Equivalent levels of Pax3DN showed
no effect, but in contrast with the observations on the hind-
limb (Fig. 7 B), when the concentration of Pax3DN was in-
creased, some cell death was observed. These results suggest
that Pax3 can have a limited antiapoptotic effect in the muscles
in which it is expressed. In keeping with this conclusion, more
myogenic colonies are present in cells isolated from the dia-
phragm of Pax7 mutant mice at P4, although in both diaphragm
and hindlimb preparations, this number was strikingly lower
than with the wild type (Fig. 7 D). At later stages no differ-
ence was detectable.
Discussion
Pax7 is a satellite cell marker; however, we now show that its
paralogue, Pax3, is coexpressed in these cells in many skeletal
muscles. This raises the question of their respective roles and
whether Pax3 can compensate for the Pax7 mutant phenotype.
Both function similarly in regulating MyoD during the onset of
myogenesis in satellite cell cultures, and our analysis of Myf5
mutant cells demonstrates that Myf5 and Pax3 or Pax7 control
the entry of these adult muscle progenitor cells into the myo-
genic program. The progressive postnatal loss of satellite cells
that we document for Pax7 mutant mice is seen in the presence
of Pax3, and it is caused by a requirement for Pax7 in muscle
satellite cell survival and cell cycle progression for which Pax3
cannot compensate.
Muscle progenitor cell specification and 
Pax3 expression in a subset of skeletal 
muscles
At birth the great majority of satellite cells are still present in
the trunk and limb muscles of Pax7 mutant mice (Oustanina et
al., 2004), showing that Pax7 is not required for satellite cell
specification as previously suggested (Seale et al., 2000).
During prenatal development, a Pax3/7 population of myo-
genic progenitor cells is present and these somite-derived
cells take up a satellite cell position in late fetal muscle (Gros
et al., 2005). It is only when both Pax3 and -7 are absent that
these cells die or fail to enter the myogenic program, with a
major deficit in skeletal muscle in the double mutant (Relaix
et al., 2005). We would therefore propose that satellite cell
progenitors are specified prenatally by the action of Pax3 in
the Pax7 mutant.
It is not clear why Pax3 should be present in the quies-
cent, as well as in the activated satellite cells of some muscles
and not others. Most hindlimb muscles, usually used as a
source of satellite cells (Seale et al., 2000; Conboy and Rando,
2002), and some forelimb and trunk muscles are negative for
Pax3. Even within a muscle that is positive, like the diaphragm,
some satellite cells express only Pax7. These differences do not
correlate with fiber type and, thus, they do not correlate with
the type of innervation. A correlation with the embryological
origin of the muscle is also not evident (Tajbakhsh and Buck-
ingham, 2000).
Heterogeneity between muscles is a well known feature
of myopathies in which the mutation of a gene expressed in all
muscles may have a pathological effect on particular muscle
groups (Hadchouel et al., 2003). It is also evident from the
study of regulatory genes in the embryo that different sites of
myogenesis are coordinated by different regulatory strategies.
This is illustrated by the number of distinct sequences that con-
trol the spatiotemporal activation of the Myf5 gene (Buch-
berger et al., 2003; Hadchouel et al., 2003) or by the effects of
mutations in genes encoding homeobox proteins, such as Lbx1
(Schafer and Braun, 1999; Brohmann et al., 2000; Gross et al.,
2000) or Meox2 (Mankoo et al., 1999), which lead to the loss
of certain limb muscles and not others. Understanding the basis
of such myogenic heterogeneity represents a challenge for the
muscle field, which has tended not to think in these terms be-
cause of the apparently generalized effects of the MyoD family
of myogenic regulatory factors in the embryo.
The role of Pax3 and -7 in myogenesis
Myogenesis in the embryo is initially orchestrated by the myo-
genic regulatory factors Myf5 and Mrf4 that, together with
Pax3, lead to the subsequent activation of MyoD. Mrf4 is not
detectable in adult satellite cells (unpublished data), although it
is expressed when they differentiate (Cooper et al., 1999), and
this gene does not play a role as a determination factor during
late embryonic and fetal development (Kassar-Duchossoy et
al., 2004, 2005). However, we show that the genetic hierarchy
that controls the onset of myogenesis in the embryo is con-
served in the adult and that Pax3/7 and Myf5 control the entry
of cells into the myogenic program, acting in parallel genetic
pathways. In the absence of all three factors, skeletal muscle
differentiation does not occur, whereas in satellite cells from
the Myf5 mutant or from Pax3-negative hindlimb muscles of
the Pax7 mutant, myogenin is activated and the cells differenti-
ate. In keeping with previous observations on MyoD mutant
embryos (Rudnicki et al., 1992), Myf5 can activate myogenin
directly, whereas activation of myogenesis by Pax3/7 depends
on MyoD, as shown in the experiments reported here (Taj-
bakhsh et al., 1997). Expression of Myf5 in satellite cells, which
we show is not affected by dominant-negative forms of Pax3 or -7,
suggests that these cells have progressed beyond the progenitor
cell state, characterized by the presence of Pax3/7 and the ab-
sence of any myogenic regulatory factor (Gros et al., 2005;
Kassar-Duchossoy et al., 2005; Relaix et al., 2005). In prenatal
progenitor cells, expression of both Myf5 and MyoD depends
on the presence of Pax3/7 factors (Relaix et al., 2005).
Dominant-negative forms of Pax3 or -7 down-regulate
MyoD expression in the presence of Myf5. Presumably, the en-
grailed repression domain present in these constructs overrides
transcriptional activation by Myf5. The direct repression ex-
erted by these constructs was demonstrated by their effect
on the P34 reporter transgene, which is dependent on Pax3/7
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Pax3DN or -7DN are expressed at a lower level, as indicated
by the GFP reporter, with only partial repression of MyoD, we
have never detected any difference between the two Pax domi-
nant-negative forms. Furthermore, satellite cells isolated from
hindlimb muscles expressing only Pax7 down-regulate MyoD
in the presence of Pax3DN. We therefore conclude that Pax3
and -7 play a similar role in the activation of MyoD and subse-
quent skeletal muscle differentiation. In experiments with ade-
noviral vectors in which Pax3 or -7 were overexpressed in sat-
ellite cells, we saw no down-regulation of MyoD. This is in
contrast to the results of the study conducted by Olguin and
Olwin (2004), although in the C2 myogenic cell line, we did
see some effect on MyoD (unpublished data). This may be a
question of the cell system and the extent of overexpression,
but we conclude that Pax3 and -7 normally act as activators
of the myogenic program. The overexpression of MyoD that
we observe in embryos that express the constitutively active
PAX3-FKHR protein is consistent with this role. We show that
Pax3, like Pax7 (Olguin and Olwin, 2004; Zammit et al., 2004),
is rapidly down-regulated as satellite cells begin to differentiate.
We observed the presence of Pax3/7-positive, MyoD-negative
cells in older cultures in which differentiated myotubes were
present. These cells probably correspond to reserve cells that
will reconstitute the satellite cell pool, taking up a satellite cell
position on newly formed fibers (Zammit et al., 2004).
Satellite cell proliferation
In satellite cultures from hindlimb muscles, we frequently saw
colonies that expressed only Pax7, with no detectable expres-
sion of the Pax3 reporter. In contrast, Pax7-positive satellite
cells from the tibialis anterior muscle, also used in our experi-
ments, have been reported to systematically activate Pax3 in
culture and it has been proposed that Pax3 is necessary for their
proliferation (Conboy and Rando, 2002). This discrepancy may
reflect problems with the Pax3 antibody used, which, in our
experience, works poorly on cultured cells and may show
cross-reactivity with Pax7. This is why we rely on different
Pax3 reporter lines, which consistently give reproducible results
(Relaix et al., 2003, 2004, 2005). When we isolate satellite cells
from Pax3
GFP/  mice by flow cytometry after injury of the tibialis
anterior, these cells remain Pax3 (GFP)-negative (Montarras et
al., 2005), consistent with our ex vivo observations. Grafting
experiments (Montarras et al., 2005), in addition to cell culture
observations, show that satellite cells retain their Pax3-positive
or -negative status independent of their environment.
In the Pax7 mutant, satellite cells are present and can dif-
ferentiate into skeletal muscle (Oustanina et al., 2004), but, as
we show, there is a progressive loss of these cells during post-
natal development. Their loss is equally evident in muscles
where Pax3 is also expressed in satellite cells. This indicates
that there must be a function of Pax7 for which Pax3 cannot
compensate. It had been suggested that there may be a prolifer-
ative defect in satellite cells in the absence of Pax7 (Oustanina
et al., 2004). We examined the proliferation of satellite cell cul-
tures from Pax7 mutant mice and observed a 25–30% reduction
compared with wild type. This was seen with Pax3-positive
myogenic colonies from the diaphragm, as well as from Pax3-
negative hindlimb muscles. All of the cells were still cycling,
but the cell cycle was perturbed, with relatively more cells in S
and G2 phases. We suggest that this effect may be attributable
to the loss of cells in G1 caused by apoptosis (Abrams and
White, 2004).
Pax7 and satellite cell survival
We show that apoptosis, marked by activated caspase-3, occurs
in the skeletal muscle of the Pax7 mutant. This is detectable
immediately after birth and appears to occur in activated satel-
lite cells, marked by desmin expression that would normally
contribute to muscle growth. This suggests that self-renewal of
satellite cells takes place via an activated cell state, as previ-
ously proposed (Zammit et al., 2004). We do not detect cell
death in cultured satellite cells from Pax7 mutant mice. This
may be because the presence of serum in the medium provides
some protection or because dying cells detach rapidly preclud-
ing detection with markers of apoptosis. Muscles, such as the
diaphragm, in which Pax3 is expressed, have more satellite
cells, giving rise to myogenic colonies when satellite cell loss
in vivo is still relatively minor (15–20%). However, by 15 d
after birth only 5% of satellite cells remain in Pax3-expressing
as well as Pax3-negative muscles. The difference between
Pax3 and -7 is demonstrated by the flow cytometry experi-
ments on satellite cells expressing dominant-negative con-
structs. Pax3DN at high levels does have some effect on the
viability  of the satellite cells in which it is expressed, but
Pax7DN is much more potent, suggesting that the antiapoptotic
targets of these two Pax factors are different in postnatal muscle.
In the embryo, muscle progenitor cells in the somite are lost in
the absence of Pax3, which is necessary for the survival of the
hypaxial dermomyotome. Pax7 is not normally expressed in
these cells, but can rescue this function (Relaix et al., 2004).
The expression of a single Pax3/7 gene in the muscle progenitor
cells present in the somites of the cephalochordate Amphioxus
(Holland et al., 1999) also suggests that Pax3 and -7 have
similar functions in this embryonic context and that the dis-
tinct antiapoptotic activity of Pax7 evolved during vertebrate
radiation, perhaps in response to the requirements of postnatal
muscle growth and regeneration.
Members of the Pax gene family, which play key roles in
the formation of other tissues (Tremblay and Gruss, 1994; Chi
and Epstein, 2002), have been implicated in several functions
discussed here for Pax3 and -7 in the skeletal muscle context.
In addition to affecting cell fate choices, roles in proliferation
and cell survival have been described. Notably, in the latter
context, cells that do not express Pax2 in the developing inner
ear undergo apoptosis (Li et al., 2004) and apoptosis is seen in
mesodermal cells, which would normally form the pronephros
during kidney development, in the absence of Pax2 and -8,
which are required for the emergence of the nephric cell lin-
eage (Bouchard et al., 2002). Furthermore, Pax2 has been
shown to prevent apoptosis in renal cell cultures (Torban et al.,
2000; Cai et al., 2005) related to its function during later neph-
rogenesis (Porteous et al., 2000). In a screen of human cancer
cell lines from a range of tissues, PAX gene expression was
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optosis (Muratovska et al., 2003). The antiapoptotic function of
Pax7, which we describe here in postnatal skeletal muscle, is
therefore not unique to this Pax subgroup. A role for Pax pro-
teins in assuring the survival of the progenitor cells in which
they regulate cell fate determinants may be widespread. The
fine-tuning of such an antiapoptotic function in progenitor cells
in the adult may also be critical in regulating the maintenance
of stem cell populations during tissue growth and regeneration.
Materials and methods
Mice
Pax3
nLacZ/  (Relaix et al., 2004) and Pax3
IRESnLacZ/  (Relaix et al., 2003)
mice were genotyped on the basis of the “splotch” phenotype (Auerbach,
1954). Pax7
LacZ/  mice (Mansouri et al., 1996) were genotyped by PCR,
using the following primers: DPax7Ex2A: CTTggCCAAggCCgggTCAAT-
CAgCTTggTggg; RLacZ3: AAATTCAgACggCAAACgACTgTCCTggCC;
and RPax7Ex3C: gATggACCCAgTCTCCTgATATCggCACAg. The wild-
type band was amplified using DPax7Ex2A/RPax7Ex3C (800 bp),
whereas the mutated allele was amplified using DPax7Ex2A/RLacZ3
(500 bp).
Cell culture
Cells were prepared from muscle tissue of mice at different time points af-
ter birth by enzymatic dissociation, as previously described (Pinset and
Montarras, 1998; Montarras et al., 2000). Cells were plated on gelatin-
coated dishes in a 1:1 mixture (vol/vol) of Ham’s F12 and DME (GIBCO
BRL) containing 20% (vol/vol) fetal calf serum (AbCys) and 2% (vol/vol)
ultroser (Biosepra). This medium, which supports both the proliferation and
differentiation of muscle cells (Montarras et al., 2000), was used in all ex-
periments. To allow the formation of colonies of muscle cells, primary cul-
tures were plated at a density of 100 and 200 cells/cm
 2. When plated
under these conditions cultures were highly enriched in myogenic colo-
nies. The number of mononucleated cells to be plated was determined by
counting after labeling an aliquot with 5  g/ml of the DNA dye bis-benz-
imide (Hoeschst).
Single fiber preparation and culture were performed according to
Beauchamp et al. (2000).
Immunocytochemical analysis
Cells were treated as previously described (Montarras et al., 2000). In brief,
after fixation with 4% (wt/vol) paraformaldehyde and permeabilization
with 0.2% (wt/vol) Triton X-100, cells were incubated with antibodies
diluted in PBS containing 0.2% (wt/vol) gelatin. All incubations were at
room temperature. For immunofluorescence, cells were mounted in mowiol
(Calbiochem) after the staining of DNA with 5  g/ml bis-benzimide in the
penultimate PBS wash.
Antibodies used were as follows: Myf5, rabbit polyclonal (Lindon et
al., 2000), at a 1:1,000 dilution; MyoD, either a rabbit polyclonal (Santa
Cruz Biotechnology, Inc.), at a 1:200 dilution, or a mouse monoclonal
(clone 5.8A; DAKO), at a 1:200 dilution; troponin T, mouse monoclonal
(clone JLT12, Sigma-Aldrich), at a 1:200 dilution; desmin, mouse mono-
clonal (clone D33; DakoCytomation), at a 1:200 dilution; laminin, rabbit
polyclonal (Sigma-Aldrich), at a 1:200 dilution; M-cadherin, mouse mono-
clonal (clone 12G4; Nanotools GmBh), at a 1:200 dilution; antiactive
caspase-3, rabbit polyclonal (BD Biosciences), at a 1:250 dilution; cyclin
A, a rabbit polyclonal (gift from A. Fernandez and N. Lamb, Institut de
Génétique Humaine, Montpellier, France), at a 1:200 dilution; Ki67, a
mouse monoclonal (BD Biosciences), at a 1:100 dilution; Pax7, mouse
monoclonal (Developmental Studies Hybridoma Bank), at a 1:100 dilu-
tion; Pax3, mouse monoclonal (provided by M. Bronner-Fraser, California
Institute of Technology, Pasadena, CA), at a 1:100 dilution;  -gal, either
rabbit polyclonal (Invitrogen), at a 1:4,000 dilution in cell culture experi-
ments, or another rabbit polyclonal used on sections (provided by J.-F.
Nicolas, Institut Pasteur, Paris, France), at a 1:500 dilution, or mouse mon-
oclonal (clone Gal13; DakoCytomation), at a 1:100 dilution. Secondary
antibodies were coupled to a fluorochrome, either Alexa 488 or 594 (In-
vitrogen), at a 1:250 dilution.
For X-Gal (Roche) staining, single fibers were fixed for 30 min with
4% paraformaldehyde in PBS, on ice. Fibers were rinsed twice with PBS,
and then stained with X-Gal, using 0.4 mg/ml X-Gal in 2 mM MgCl2,
0.02% NP-40, 0.1 M PBS, pH 7.5, 20 mM K4Fe(CN)6, and 20 mM
K3Fe(CN)6 for 4–16 h at 37 C, with shaking. Fibers were rinsed in PBS,
postfixed overnight in 4% paraformaldehyde, and mounted after washing
in PBS-buffered mowiol with DAPI. Similar conditions were used for X-Gal
staining of sections. X-Gal staining of cells was performed after a 5-min
fixation in 4% paraformaldehyde in the same solution used for fibers, but
without NP-40.
Images of cultured cells and sections were acquired using an Axio-
phot or an Apotome equipped with an Axiocam camera and Axiovision
software (Carl Zeiss MicroImaging, Inc.). Neofluar lenses, 40 , NA
0.75, and 20 , NA 0.50, were used. Images were optimized globally
for contrast and brightness and assembled using Photoshop CS software
(Adobe).
Analysis of extracts by semiquantitative RT-PCR
RNA extracts were prepared from tibialis anterior and diaphragm muscles
of 8-wk-old mice, using TRIzol (Invitrogen). Reverse transcripts were gener-
ated using Power Script reverse transcriptase (BD Biosciences). The prim-
ers for Pax3 were DPax3-740 (TGCCCTCAGTGAGTTCTATCAGC) and
RPax3-1100 (GCTAAACCAGACCTGCACTCGGGC), which generate a
360-bp PCR fragment. The primers for Pax7 were Dpax7-140 (TGG-
AAGTGTCCACCCCTCTTGGC) and RPax7-650 (ATCCAGACGGTTC-
CCTTTGTCGCC), which generate a 510-bp PCR fragment. Three other
primer pairs were used and gave similar results. PCR products were sepa-
rated on 1.5% agarose gels, using standard techniques, and revealed by
UV light (Image Master CVS; GE Healthcare).
Analysis of extracts by Western blotting
Protein extracts were prepared and analyzed by Western blotting, as pre-
viously described (Lindon et al., 2000). The antitubulin antibody (clone
5HI; BD Biosciences) was used at a 1:2,000 dilution and the Pax3 anti-
body at a 1:400 dilution.
Preparation of adenoviral vectors and cell infection
Adenoviral vectors were generated using standard molecular biology
techniques. In brief, dominant-negative Pax3 and -7 constructs were made
by fusing in-frame sequences encoding the D. melanogaster engrailed re-
pression domain (298 amino acids; Han and Manley, 1993) to the first
340 amino acids of murine Pax7 (to generate the Pax7DN construct) or
the first 374 amino acids of Pax3 (to generate the Pax3DN construct).
Dominant-negative activity of Pax7DN and -3DN was verified by cotrans-
fection in 293 cells with a plasmid containing polymerized Pax3/7 bind-
ing sites (Epstein et al., 1996) in front of a thymidine kinase (Herpes virus)
minimal promoter followed by a LacZ reporter gene. Before their introduc-
tion into the adenovector, Pax7DN and -3DN were cloned into the
Adtrack-CMV shuttle vector and recombinant adenoviruses with a GFP re-
porter sequence were generated as described previously (He et al.,
1996). High-titer viral stocks were prepared by repeated infection into the
packaging cell line 293T. Viruses were purified by CsCl banding followed
by passage through a 2.5-ml Sephadex G25 column (GE Healthcare) for
desalting and stored in aliquots at  80 C. The titer of each preparation
was determined after infection of 293 cells by limiting dilution of virus and
detection of GFP expression.
Primary cultures of muscle cells were infected 3 d after plating on
35-mm dishes. The medium was removed, but a film of medium (0.3 ml)
was left to prevent drying and virus was added to each dish for 30 min at
37 C at a multiplicity of infection of 5–30 (Results). 1.5 ml of medium was
added to the cells that were analyzed 3 d later by immunofluorescence
and flow cytometry.
Flow cytometry
Flow cytometric analysis and characterization of (Pax3) GFP-positive cells
present in skeletal muscles of adult Pax3
GFP/  mice have permitted us to
define parameters for isolating adult muscle progenitor cells both from
Pax3-expressing muscles (e.g., diaphragm) and non-Pax3–expressing
muscles (e.g., lower hindlimb muscles; Montarras et al., 2005). In the
case of the latter, this was on the basis of the size and granularity of
CD34
  cells. GFP-positive muscle progenitor cells from diaphragm muscle
and GFP-negative muscle progenitor cells from lower hindlimb muscles,
isolated by flow cytometry, were maintained in culture for 6 d as prolifer-
ating cells before a second flow cytometric analysis for detecting the pres-
ence of GFP-positive cells.
Flow cytometry analysis was performed with an LSR analyzer
(Becton Dickinson) and cell sorting was performed with a Moflo (Cytoma-
tion, Inc.). Antibody against CD34 was a mouse monoclonal clone (clone
Ram [34]; Becton Dickinson), coupled to biotin, and detected with strepta-
vidin coupled to phycoerythrin. Cell death was measured by PI staining ofPAX7 IS ESSENTIAL FOR MUSCLE SATELLITE CELL SURVIVAL • RELAIX ET AL. 101
adenovirus-infected cells, which were identified by GFP fluorescence.
Cells were trypsinized and pooled with the culture supernatants before
addition of 1  g/ml PI and flow cytometry. Each determination was from
triplicate plates.
Online supplemental material
Fig. S1 presents an analysis of satellite cells present on single fibers iso-
lated from the extensor digitorum longus hindlimb muscle of Pax7 / 
and Pax7 /  mice at P10. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200508044/DC1.
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